Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus

Am J Cardiol. 2002 Dec 1;90(11):1254-7. doi: 10.1016/s0002-9149(02)02847-3.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brachial Artery / drug effects
  • Brachial Artery / physiology
  • Diabetes Mellitus, Type 2 / complications
  • Double-Blind Method
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology
  • Female
  • Fenofibrate / pharmacology*
  • Fenofibrate / therapeutic use
  • Humans
  • Hyperlipidemias / drug therapy*
  • Hyperlipidemias / etiology
  • Hypolipidemic Agents / pharmacology*
  • Hypolipidemic Agents / therapeutic use
  • Male
  • Middle Aged
  • Regional Blood Flow / drug effects
  • Risk Factors
  • Treatment Outcome
  • Vasodilation / drug effects*

Substances

  • Hypolipidemic Agents
  • Fenofibrate